Learn more about HPV vaccination.
HPV vaccines are among the most effective vaccines available to date, learn more about how we are working with the global community to expand access to these vaccines.
The Full Picture
Cervical cancer is the 4th most common cancer among women.
In 2018, an estimated 570,000 women worldwide were diagnosed with cervical cancer and about 311,000 died from cervical cancer. 85% of the burden falling on women from lower-middle income countries. Human papillomavirus is linked to 99% of all cervical cancer cases.
The HPV vaccine prevents over 90% of HPV-related cancers,
along with other prevention practices.
CHIC aims to increase access to the HPV vaccine
by strengthening the HPV immunization community.
CHIC’s mission is to effectively translate implementation research findings
to guide practice and more equitable access to immunization within the context on an increasingly stable HPV vaccine market.
Briefing on HPV and Vaccination
This briefing on HPV and vaccination explains the disproportionate global burden of cervical cancer on LMICs and the significant barriers in the implementation of vaccination programs.
Human Papillomavirus – The Current Landscape of HPV Vaccines Globally and the CHIC Project
The slide deck explains the global burden of HPV-related cervical cancer, the current landscape of HPV vaccines, and the goals of the CHIC project.
World Health Organization, Departmental News | 7/6/2021
Progress and Challenges with Sustaining and Advancing Immunization Coverage During the COVID-19 Pandemic
WUENIC | July 6, 2021
As deadly surge of COVID-19 sweeps across South Asia, UNICEF calls for US$164 million to help save lives
UNICEF | May 21, 2021